Acusense Attends ERA Congress 2023 in Milan
In June 2023, Acusense participated in the 60th Congress of the European Renal Association (ERA) held in Milan, Italy. Organized by ERA and combining both in-person and virtual formats, the congress brought together leading experts, researchers, and industry professionals in the field of nephrology from around the world.
As one of the most prestigious and influential academic events in nephrology, the ERA Congress showcased cutting-edge developments in both basic and clinical research, alternative therapies, transplantation technologies, and advances in diabetic nephropathy and internal medicine. At the event, Acusense presented its latest innovation in hemodialysis safety—a proprietary venous needle dislodgement and bleeding alert system. This breakthrough technology represents a major step forward in enhancing the safety and effectiveness of dialysis treatment, demonstrating Acusense’s ongoing commitment to improving patient care and clinical outcomes. The innovation was met with strong interest and positive feedback from attending experts.
By participating in such a prominent international academic forum, Acusense not only showcased its technological capabilities in nephrology treatment but also strengthened collaboration and dialogue with global peers. These interactions provided valuable industry insights and laid a solid foundation for future R&D and international market expansion.
Acusense remains dedicated to advancing nephrology technologies and delivering high-quality medical solutions to patients worldwide.
